Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT05887817
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT05887817
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Japan
- Registry status
- Unknown status
Technical summary
Registry record NCT05887817. Randomized; quadruple masking; primary purpose treatment. Start 2023-09-07 (actual); primary completion 2025-02-28 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
- Acronym
- FIVE-STAR
- Condition
- Type 2 Diabetes
- Condition
- Chronic Kidney Diseases
- Intervention (Drug)
- Finerenone
- Intervention (Drug)
- Placebo
- Lead sponsor
- Saga University
Record details
- Record id
cardio:ct-nct05887817- Content hash
e9e2701ecf2d24fd29b63e027b7d947128b4dead3fe4c8d69e603c091c4b4898